Reno, NV, United States of America

Robert W Egan

USPTO Granted Patents = 6 

Average Co-Inventor Count = 5.7

ph-index = 2

Forward Citations = 71(Granted Patents)


Company Filing History:


Years Active: 1995-2025

Loading Chart...
6 patents (USPTO):

Title: Innovations and Contributions of Robert W. Egan

Introduction

Robert W. Egan is a notable inventor based in Reno, NV, with a significant portfolio of six patents. His work primarily focuses on advancements in the field of biopharmaceuticals and protein analysis. Egan's innovative approaches have contributed to the understanding of biomolecular structures and their interactions.

Latest Patents

Egan's latest patents include the development of an opto-fluidic array for radical protein foot-printing. This invention presents systems and methods for both in vivo and in vitro radical protein foot-printing using an opto-fluidic array. These teachings are instrumental in studying three-dimensional protein structures and bio-kinetics. The use of radical dosimetry, including an optional intrinsic standard, allows for real-time feedback, ensuring comparability between different experiments and analysis results that reflect actual biological conditions. Another significant patent involves radical dosimetry methods for in vivo hydroxyl radical protein foot-printing, utilizing a flash photo-oxidation device for higher order structural analysis of biomolecules. This analysis is crucial for understanding the therapeutic properties of biotherapeutics, which are dependent on their higher order structure.

Career Highlights

Throughout his career, Robert W. Egan has worked with prominent companies such as Gennext Technologies, Inc. and Hewlett-Packard Company. His contributions in these roles have been pivotal in advancing technologies related to protein analysis and biopharmaceuticals.

Collaborations

Egan has collaborated with notable individuals in his field, including Scot Randy Weinberger and Ronald Carl Orlando. These partnerships have further enhanced the impact of his innovations.

Conclusion

Robert W. Egan's contributions to the field of biopharmaceuticals and protein analysis through his patents and collaborations highlight his role as a significant inventor. His work continues to influence advancements in understanding biomolecular structures and their applications in therapeutic development.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…